Clinical Trial Update: Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of Genexol-PM versus Genexol in recurrent or metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Genexol (Paclitaxel)
• Genexol-PM (paclitaxel)

Snippet

Sponsor: Samyang Biopharmaceuticals Corporation | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED